Icahn Raises Stake in Amylin Pharmaceuticals, Inc. to 7.3 Percent

LOS ANGELES, Sept 12 (Reuters) - Billionaire investor Carl Icahn has raised his stake in biotechnology company Amylin Pharmaceuticals Inc to 7.33 percent, according to documents filed on Friday with the U.S. Securities and Exchange Commission.